Biogen, Inc. (BIIB)

172.68 +7.30 (+4.41%) USD  |  NASDAQ  |  Jan 21, 16:00
171.67 -1.01 (-0.58%) After-Hours: 16:38
More

Biogen Security Sold Not Yet Repurchased (Quarterly)

Security Sold Not Yet Repurchased (Quarterly) Chart

View Security Sold Not Yet Repurchased (Quarterly) for BIIB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Security Sold Not Yet Repurchased (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Security Sold Not Yet Repurchased (Quarterly) Range, Past 5 Years

View Security Sold Not Yet Repurchased (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Security Sold Not Yet Repurchased (Quarterly) Benchmarks

View Security Sold Not Yet Repurchased (Quarterly) Benchmarks
Start Trial
Eli Lilly & Co. --
AbbVie, Inc. --
Stoke Therapeutics, Inc. --
Alnylam Pharmaceuticals, Inc. --
Insmed, Inc. --